BRAF Inhibitors for BRAF V600E Mutant Colorectal Cancers: Literature Survey and Case Report

The main method of fighting against colon cancer is targeted treatment. BRAF inhibitors, which are accepted as standard treatment for V600E mutant malign melanomas, are the newest approach for targeted treatment of V600E mutant colorectal cancers. In this case report, we share our experience about t...

Descripción completa

Detalles Bibliográficos
Autores principales: Peker, Yasar Subutay, Can, Mehmet Fatih, Ozerhan, Ismail Hakki, Yagci, Gokhan, Zeybek, Nazif, Kavakli, Kutan, Gurkok, Sedat, Gozubuyuk, Alper, Genc, Onur, Erdem, Gokhan, Ozet, Ahmet, Gerek, Mustafa, Peker, Yusuf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925159/
https://www.ncbi.nlm.nih.gov/pubmed/29850361
http://dx.doi.org/10.1155/2018/8782328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925159/
https://www.ncbi.nlm.nih.gov/pubmed/29850361
http://dx.doi.org/10.1155/2018/8782328

Ejemplares similares